The Relationship between Personality Traits, the 5HTT Polymorphisms, and the Occurrence of Anxiety and Depressive Symptoms in Elite Athletes

PLoS One. 2016 Jun 3;11(6):e0156601. doi: 10.1371/journal.pone.0156601. eCollection 2016.

Abstract

The purpose of this study was to determine the relationship between personality, the serotonin transporter (5HTT) polymorphisms and the occurrence of anxiety and depressive symptoms in elite athletes. 133 healthy participants completed the NEO Five-Factor Inventory (NEO-FFI). The mood states were assessed using the Profile of Mood States (POMS) questionnaire. The athlete's mental skills were assessed through the Sport Performance Psychological Inventory (IPPS-48). The occurrence of psychiatric and personality disorders was assessed using the Clinical Interview for DSM-IV Disorders. A polymerase chain reaction was employed to identify genotypes at the 5HTTLPR polymorphism. The 5HTTLPR s/s genotype was associated with both neuroticism (p< 0.001) and tension/anxiety symptoms according to the POMS (p<0.02), cognitive anxiety and emotional arousal control according to the IPPS-48 (p<0.01). Significant correlations were proved between neuroticism and symptoms of anxiety and depression (p<0.05). Neuroticism mediates the association between the 5HTTLPR polymorphism and symptoms of cognitive anxiety and emotional arousal control (p<0.05). These results suggest a significant interaction between the 5HTTLPR polymorphism, neuroticism and sport related stress that predict adverse mental health outcomes in athletes. Identification of homogeneous groups of athletes having predispositions to anxiety and depressive symptoms may help to implement early prevention programs.

MeSH terms

  • Adolescent
  • Adult
  • Anxiety / genetics*
  • Athletes*
  • Depression / genetics*
  • Female
  • Genotype
  • Healthy Volunteers
  • Humans
  • Male
  • Personality*
  • Polymorphism, Genetic
  • Psychometrics
  • Risk Factors
  • Serotonin Plasma Membrane Transport Proteins / genetics*
  • Young Adult

Substances

  • Serotonin Plasma Membrane Transport Proteins

Grants and funding

The authors have no support or funding to report.